11.2 Capital

Type

Venture Capital

Status

Active

Location

San Francisco, United States

Total investments

44

Average round size

19M

Portfolio companies

34

Rounds per year

4.00

Lead investments

3

Follow on index

0.23

Exits

5

Stages of investment
SeedEarly Stage Venture
Areas of investment
BiotechnologySoftwareAnalyticsInformation TechnologyArtificial IntelligenceMachine LearningHealth CareRoboticsMedicalTherapeutics

Summary

11.2 Capital appeared to be the VC, which was created in 2014. The venture was found in North America in United States. The leading representative office of defined VC is situated in the San Francisco.

Comparing to the other companies, this 11.2 Capital performs on 25 percentage points less the average number of lead investments. The average startup value when the investment from 11.2 Capital is 100-500 millions dollars. The high activity for fund was in 2015. Despite it in 2019 the fund had an activity. The increased amount of exits for fund were in 2016. The fund is constantly included in 2-6 investment rounds annually. Speaking about the real fund results, this VC is 16 percentage points less often commits exit comparing to other organizations. The common things for fund are deals in the range of 10 - 50 millions dollars.

This organization was formed by Shelley Zhuang. We also calculated 1 valuable employee in our database.

The typical case for the fund is to invest in rounds with 4-5 participants. Despite the 11.2 Capital, startups are often financed by Y Combinator, Felicis Ventures, Creative Destruction Lab. The meaningful sponsors for the fund in investment in the same round are Y Combinator, SV Angel, First Round Capital. In the next rounds fund is usually obtained by Y Combinator, Khosla Ventures, Data Collective DCVC.

Among the most popular portfolio startups of the fund, we may highlight Cruise Automation, Ginkgo BioWorks, Lucira Health. The fund has no specific favorite in a number of founders of portfolio startups. Besides, a startup needs to be aged 2-3 years to get the investment from the fund. Among the most popular fund investment industries, there are Genetics, Health Care. For fund there is a match between the location of its establishment and the land of its numerous investments - United States.

Show more

Investor highlights

Industry focus
AI/Big DataCybersecurityDeep TechRoboticsAerospace Show 2 more
Stage focus
Seed
Geo focus
Generalist
Check size
500K — 3M

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Last fund

Fund size
USD 101000000
Fund raised date
2021-11-01

Analytics

Total investments
44
Lead investments
3
Exits
5
Rounds per year
4.00
Follow on index
0.23
Investments by industry
  • Software (21)
  • Health Care (12)
  • Artificial Intelligence (9)
  • Information Technology (9)
  • Analytics (8)
  • Show 60 more
Investments by region
  • United States (36)
  • United Kingdom (3)
  • Canada (3)
  • Germany (1)
Peak activity year
2020
Number of Unicorns
2
Number of Decacorns
3
Number of Minotaurs
2

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
7
Avg. valuation at time of investment
341M
Group Appearance index
0.95
Avg. company exit year
4
Avg. multiplicator
0.08
Strategy success index
0.60

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Coalesce Automation 04 Apr 2024 Software, Analytics, Data Integration, Data Center Automation Early Stage Venture 50M United States, California, San Francisco
TigerGraph 14 Nov 2013 Software, Analytics, Machine Learning, Enterprise Software, Big Data, Real Time, Database, Data Visualization Seed 2M United States, California, Redwood City

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.